<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupKathryn Alsop, Gillian Mitchell, Sián Fereday et al.|Journal of Clinical Oncology|2012Cited by 1.2k
The 2019 World Health Organization classification of tumours of the breastPuay Hoon Tan, Roberto Salgado, Anna Sapino et al.|Histopathology|2020Cited by 1.1k
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain TumorsShona Hendry, Stephen B. Fox|Advances in Anatomic Pathology|2017Cited by 795
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III TrialDanny Rischin, Grant A. McArthur, Richard J. Young et al.|Journal of Clinical Oncology|2010Cited by 741
No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomasWen Qiu, Ian Campbell, Min Hu et al.|Nature Genetics|2008Cited by 280